Cohen Pontani Lieberman & Pavane Partner Alan Morrison Contributes to Book on Antibody Engineering

New York, NY, December 18, 2008 --(PR.com)-- Alan J. Morrison, a partner in the New York City law firm of Cohen Pontani Lieberman & Pavane LLP, has been tapped to author a subchapter on U.S. patent enforcement methods for inclusion in the tentatively titled IP Issues in the Therapeutic Antibody Industry by Dr. Ulrich Storz, a partner in the Düsseldorf law firm of Michalski Huettermann & Partner.

According to Morrison, “Developments in recombinant antibody technology have resulted in a proliferation of therapeutic antibody patents internationally. These patents, like others in the biotech and pharmaceutical fields, are being enforced with increasing frequency.”

Mr. Morrison’s sub-chapter will provide a general synopsis of U.S. enforcement procedures. IP Issues in the Therapeutic Antibody Industry will be included in the 2009 edition of Antibody Engineering published by Springer Lab Manuals.

###

Cohen Pontani Lieberman & Pavane LLP (www.cplplaw.com) is an intellectual property firm serving a worldwide roster of companies from a diverse range of industries including avionics, pharmaceuticals, electronics, heavy machinery, biotechnology and telecommunications.

CPLP is unique in its focus on intellectual property litigation that infuses every aspect of its IP work in prosecution of patents, trademarks, and copyrights; in drafting opinions and licenses; and in due diligence and transactional work.

It is CPLP’s philosophy that no legal activity is so routine that it does not have the potential to become the weak link in IP protection, resulting in legal exposure or porous rights. Hence, the firm views all IP matters as potential litigations to be won or avoided and is positioned to provide world-class litigation services, as well as other highly skilled IP services to achieve wraparound IP protection at the highest level.